Abstract:The candidate-gene approach in association studies of polygenic diseases has often yielded conflicting results. In this hospital-based case-control study with 696 white patients newly diagnosed with bladder cancer and 629 unaffected white controls, we applied a multigenic approach to examine the associations with bladder cancer risk of a comprehensive panel of 44 selected polymorphisms in two pathways, DNA repair and cell-cycle control, and to evaluate higher-order gene-gene interactions, using classification and regression tree (CART) analysis. Individually, only XPD Asp312Asn, RAG1 Lys820Arg, and a p53 intronic SNP exhibited statistically significant main effects. However, we found a significant gene-dosage effect for increasing numbers of potential high-risk alleles in DNA-repair and cell-cycle pathways separately and combined. For the nucleotide-excision repair pathway, compared with the referent group (fewer than four adverse alleles), individuals with four (odds ratio [OR] = 1.52, 95% CI 1.05-2.20), five to six (OR = 1.81, 95% CI 1.31-2.50), and seven or more adverse alleles (OR = 2.50, 95% CI 1.69-3.70) had increasingly elevated risks of bladder cancer (P for trend <.001). Each additional adverse allele was associated with a 1.21-fold increase in risk (95% CI 1.12-1.29). For the combined analysis of DNA-repair and cell-cycle SNPs, compared with the referent group (< 13 adverse alleles), the ORs for individuals with 13-15, 16-17, and >= 18 adverse alleles were 1.22 (95% CI 0.84-1.76), 1.57 (95% CI 1.05-2.35), and 1.77 (95% CI 1.19-2.63), respectively (P for trend = .002). Each additional high-risk allele was associated with a 1.07-fold significant increase in risk. In addition, we found that smoking had a significant multiplicative interaction with SNPs in the combined DNA-repair and cell-cycle-control pathways (P < .01). All genetic effects were evident only in "ever smokers" (persons who had smoked >= 100 cigarettes) and not in "never smokers." A cross-validation statistical method developed in this study confirmed the above observations. CART analysis revealed potential higher-order gene-gene and gene-smoking interactions and categorized a few higher-risk subgroups for bladder cancer. Moreover, subgroups identified with higher cancer risk also exhibited higher levels of induced genetic damage than did subgroups with lower risk. There was a significant trend of higher numbers of bleomycin- and benzo[a]pyrene diol-epoxide (BPDE)-induced chromatid breaks (by mutagen-sensitivity assay) and DNA damage ( by comet assay) for individuals in higher-risk subgroups among cases of bladder cancer in smokers. The P for the trend was .0348 for bleomycin- induced chromosome breaks, .0036 for BPDE-induced chromosome breaks, and .0397 for BPDE-induced DNA damage, indicating that these higher-order gene-gene and gene-smoking interactions included SNPs that modulated repair and resulted in diminished DNA-repair capacity. Thus, genotype/phenotype analyses support findings from CART analyses. This is the first comprehensive study to use a multigenic analysis for bladder cancer, and the data suggest that individuals with a higher number of genetic variations in DNA-repair and cell-cycle control genes are at an increased risk for bladder cancer, confirming the importance of taking a multigenic pathway-based approach to risk assessment.

Comprehensive Pathway-Based Interrogation of Genetic Variations in the Nucleotide Excision DNA Repair Pathway and Risk of Bladder Cancer

Genetic Variations in Base Excision Repair Pathway and Risk of Bladder Cancer: A Case-Control Study in the United States

Abstract A1: Comprehensive Analyses of DNA Repair Pathways, Smoking, and Bladder Cancer Risk in Los Angeles and Shanghai

High-Order Interactions among Genetic Polymorphisms in Nucleotide Excision Repair Pathway Genes and Smoking in Modulating Bladder Cancer Risk

Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle–Control Genes

The Association of Rs710886 in Lncrna PCAT1 with Bladder Cancer Risk in a Chinese Population.

High-order Interactions among Genetic Variants in DNA Base Excision Repair Pathway Genes and Smoking in Bladder Cancer Susceptibility.

Nucleotide excision repair genes and lung cancer risk: A pathway-based approach

Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Bladder Cancer

Profiling of Genetic Variations in Inflammation Pathway Genes in Relation to Bladder Cancer Predisposition

Multigenic and Dietary Analysis of Bladder Cancer Risk on Special Reference on Nucleotide Excision Repair and Folate Intake

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer

Genetic Variants in the Wnt/β-Catenin Signaling Pathway As Indicators of Bladder Cancer Risk.

Pathway Analysis of Bladder Cancer Genome-Wide Association Study Identifies Novel Pathways Involved in Bladder Cancer Development

Genetic Variants in Telomere-Maintenance Genes and Bladder Cancer Risk.

Abstract 1667: Pathway Analysis of Bladder Cancer Genome-Wide Association Study Identifies Several Novel Pathways Involved in Bladder Cancer Development

HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer

Abstract 3593: Genetic Variants in NER Pathway Genes and Ovarian Cancer Risk and Outcomes

Evaluation Of Genetic Variants In Microrna-Related Genes And Risk Of Bladder Cancer

Nucleotide Excision Repair Gene Polymorphisms And Recurrence After Treatment For Superficial Bladder Cancer

Genetic Variants in NAMPT Predict Bladder Cancer Risk and Prognosis in Individuals from Southwest Chinese Han Group.